United Therapeutics Corporation
Status: Publicly traded
Direct answer
United Therapeutics Corporation is publicly traded on NASDAQ under the ticker UTHR.
United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial...
Can you invest in United Therapeutics Corporation?
Yes. United Therapeutics Corporation trades publicly on NASDAQ as UTHR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for United Therapeutics Corporation
Detailed equity research is provided by MarketSnap.